- The Trump administration is pushing for a significant increase in domestic semiconductor production. Earlier this year, Apple agreed to use Intel-manufactured chips in some of its products, fitting into the broader trend of bringing more semiconductor production back to the U.S.
- One scenario under consideration would involve SK Hynix leasing part of Intel’s planned manufacturing facility in Ohio. Another option could be a joint venture, potentially involving hyperscalers seeking to secure long-term memory chip supply.
- Any potential deal could face resistance from the South Korean government, as SK Hynix’s memory business is viewed as strategically important for the country.
- Intel did not comment directly on the reports, but stressed that it remains committed to the Ohio project and continues to invest in preparing the site for production.
- SK Hynix said it is exploring various options to strengthen its global competitiveness, but no agreement has been reached and no decision has been made regarding memory production in the U.S.
Intel stock chart (INTC.US)
In August 2025, the U.S. government took a 10% stake in Intel, and since then the stock has risen more than fourfold. Today, shares opened with a bullish gap and are among the strongest performers in the Nasdaq 100, although part of the initial gains has already been erased. The stock has stalled near the 50-day EMA around $101 per share.
The main resistance area appears to be around $105-$106, where significant price reactions were seen in August. A breakout above this zone could potentially open the way toward $130. Intel shares are still trading around 25% below their all-time highs.

Source: xStation5
Russia is taking over Nestlé's domestic assets 🍫 Shares are down nearly 3% 💥
Market warp: Rate Forecasts and Semiconductors in the Spotlight
Daily Summary: Hawkish Fed fails to scare the markets (17.09.2026)
Nasdaq 100 Up 1.7%
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.